• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON CONSUMER INC. NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH; DRESSING, WOUND, OCCLUSIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON CONSUMER INC. NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH; DRESSING, WOUND, OCCLUSIVE Back to Search Results
Model Number 070501064368
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Discomfort (2330); Skin Inflammation/ Irritation (4545)
Event Date 12/16/2023
Event Type  Injury  
Event Description
A 17 year old male consumer reported that he experienced discomfort using neutrogena stubborn acne ultra thin blemish patch dots.Consumer reported having a severe irritation near his eyes and forehead.It was reported that the symptoms improved after the patient stopped using the product.Consumer sought medical intervention from physician and given prescribed hydrocortisone cream for treatment and chamomile bags.
 
Manufacturer Narrative
Johnson & johnson consumer, inc.Is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which johnson & johnson consumer, inc.Has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, johnson & johnson consumer, inc.Or its employees that the report constitutes and admission that the device, johnson & johnson consumer, inc., or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.D1, d2, d3, d4: this report is for one (1) neutrogena stubborn acne ultra thin blemish patch dots 24ct usa 070501064368.D4: udi # (b)(4).Upc #: 070501064368.Expiration date: na.Lot #: 2063c.D9: device is not expected to be returned for manufacturer review/investigation.H3, h4, h6: device evaluation/investigation could not be completed; no conclusion could be drawn as product was not returned to manufacturer.A review of the device history records has been requested.H6: health effect clinical code: e1720 also refers to consumer alleged having & irritation near eyes and forehead.This event is reported as an overabundance of caution.It was reported that following use of product consumer developed severe irritation near eyes and on forehead and was left with discomfort.The consumer consulted hcp and was treated with topical medication.No direct report of aggravation/worsening of pre-existing condition in available information.Based on available information, no hospitalization, no significant intervention reported.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Manufacturer Narrative
Johnson & johnson consumer, inc.Is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which johnson & johnson consumer, inc.Has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, johnson & johnson consumer, inc.Or its employees that the report constitutes an admission that the device, johnson & johnson consumer, inc., or its employees caused or contributed to the potential event described in this report.Device was used for treatment, not diagnosis.Updated information: d4: udi # (b)(4).Upc #: (b)(4).Expiration date: 06/30/2026.Lot #: 2063c.Device history records review was completed.No non-conformance reports were generated during production.Review of the device history records showed that there were no issues during the manufacture of the product that would contribute to this complaint condition and product was manufactured per specification.The product was manufactured on july 23, 2023.If information is obtained that was not available for the follow-up #1 medwatch, an additional follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUTROGENA STUBBORN ACNE ULTRA THIN BLEMISH PATCH
Type of Device
DRESSING, WOUND, OCCLUSIVE
Manufacturer (Section D)
JOHNSON & JOHNSON CONSUMER INC.
199 grandview rd
skillman NJ 08558 9418
Manufacturer (Section G)
COLOPLAST
coloplast hungary kft.
h-4300 nyirbator
coloplast u.2
HU  
Manufacturer Contact
michael connaughton
199 grandview rd
skillman, NJ 08558-9418
9086555919
MDR Report Key18484277
MDR Text Key332558253
Report Number2214133-2024-00001
Device Sequence Number1
Product Code NAD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 01/17/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number070501064368
Device Lot Number2063C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Initial Date Manufacturer Received 12/27/2023
Initial Date FDA Received01/10/2024
Supplement Dates Manufacturer Received01/17/2024
Supplement Dates FDA Received02/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/23/2023
Is the Device Single Use? Yes
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age17 YR
Patient SexMale
-
-